Northland Capital Markets analyst Luke Horton initiates coverage on Cardlytics (NASDAQ:CDLX) with a Outperform rating and announces Price Target of $14.
Northland Capital Markets Initiates Coverage On Cardlytics With Outperform Rating, Announces Price Target of $14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.